Results for this period
Full year1 April 2025–31 March 2026Non-consolidated (standalone)Japanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
The customer base expanded as the number of personnel stationed at customer sites increased, new orders grew, Co.Hub was introduced at new drugstore chains and related services expanded, the number of PromOS accounts increased, and cross-selling to existing and new customers progressed.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Non-consolidated (standalone) |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥15,092 million (YoY +23.0%) |
| Operating profit | ¥1,686 million (YoY +68.8%) |
| Ordinary income | ¥1,742 million (YoY +70.9%) |
| Profit attributable to owners of the parent | ¥1,230 million (YoY +89.3%) |
| Net income per share | ¥173.32 |
| Operating Margin | 11.2% |
| Equity ratio | End of the current fiscal period 74.8% / End of previous period 77.4% |
| Total assets | ¥12,440 million |
| Net assets | ¥9,318 million |
| Cash flows from operating activities | ¥360 million |
| Cash flows from investing activities | ¥-1,127 million |
| Cash flows from financing activities | ¥214 million |
| Cash and cash equivalents at end of period | ¥3,107 million |
| Full-year earnings forecast | Net Sales ¥15,400 million (YoY +2.0%) / Operating profit ¥2,040 million (YoY +21.0%) / Ordinary income ¥2,100 million (YoY +20.5%) / Net income for the current fiscal year ¥1,350 million (YoY +9.7%) |
| Annual Dividend Forecast | ¥70 → ¥77（+10.0%） |
| Payout ratio | 40.4% |
| Depreciation and amortization | ¥264 million |
| Breakdown of extraordinary income (loss) | Gain on sale of non-current assets ¥1,875 thousand, Loss on Disposal of Fixed Assets ¥3,113 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Institutional investors and analysts |
| Issued Shares at Period-End | 7,103,296 Shares |
| Treasury Shares at Period-End | 0 shares |
| Factors Behind Changes in Business Performance | The customer base expanded as the number of personnel stationed at customer sites increased, new orders grew, Co.Hub was introduced at new drugstore chains and related services expanded, the number of PromOS accounts increased, and cross-selling to existing and new customers progressed. |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The customer base expanded as the number of personnel stationed at customer sites increased, new orders grew, the Co.Hub joint delivery service was introduced at new drugstore chains and related services expanded, and the number of PromOS accounts increased alongside progress in cross-selling.